QGEN Qiagen NV Company Future Sales Volume

Qiagen (QGEN) - corporate logo

The molecular diagnostics market relies on an installed base of analyzers that generate a steady stream of revenue from consumables. The future sales volume of the company on the GURU.Markets chart reflects financial stability dynamics, where 2.99 expresses the metric's value today. Qiagen N.V. (QGEN) is recognized as the global gold standard for DNA extraction, maintaining supply chain stability amid moderately low geopolitical risks.

Qiagen N.V. - QGEN Company Future Sales (period 07/04/2022 - 11/18/2026)

QGEN (Qiagen Group): analytical breakdowns and indicator data

- current price and projected stock value:
Analysis of all company metrics:QGEN Qiagen Group
Brand item of Qiagen NV

For Qiagen N.V. (QGEN), with its business model based on the sale of closed systems and consumables, this indicator reflects projected revenue by measuring the potential for customer base expansion and reagent consumption volumes. Anomalies in sales expectations for the company's products signal failures in corporate governance or a sharp shift in market demand, requiring investors to verify the operational resilience of the business.

Who Qiagen N.V. competes with

Company Future Sales Volume TEM (Tempus AI)|Projected Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Projected Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Expected Sales Volume|CRSP - Company Projected Revenue|Company Future Sales genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Projected Revenue|Company Expected Sales Volume Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Projected Sales Volume|Company Expected Sales Volume Twist Bioscience Corp TWST|Projected Sales Volume TXG|Projected Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Future Sales Volume|BioLife Solutions Inc (BLFS) - Company Expected Sales Volume|wavelifesciences.com - Projected Sales Volume|Maze Therapeutics Corp (MAZE) - Company Future Sales Volume|SION: Projected Sales Volume|Company Revenue Forecast PRME|Company Projected Revenue Taysha Gene Therapies|Company Revenue Forecast QURE (uniQure)|Company Projected Revenue MeiraGTx (MGTX)|REGENXBIO Corp - Company Revenue Forecast|Company Projected Revenue Solid Biosciences SLDB|OCGN - Company Future Sales Volume|pacb.com - Projected Sales Volume|Benitec (BNTC) - Company Future Sales Volume|DSGN: Projected Sales Volume|RCKT - Company Future Sales|FDMT: Company Future Sales|Company Revenue Forecast LXEO (lexeotx.com)|Company Projected Revenue Korro Bio Inc. (KRRO)|Company Projected Revenue Volume EDIT|Projected Sales Volume SLN (Silence Therapeutics PLC)|Company Future Revenue PRQR|CDXS - Company Projected Revenue|SGMO (Sangamo Therapeutics) - Company Revenue Forecast|NAUT: Projected Sales Volume|Company Revenue Forecast MGX|DTIL (precisionbiosciences.com) - Projected Sales Volume|Company Revenue Forecast GBIO (Generation Bio Co.)|Company Projected Revenue Boundless Bio (BOLD)|Exicure - Company Revenue Forecast|Projected Sales Volume IMNN (imunon.com)|Company Future Sales Phio Pharmaceuticals (PHIO)|MBIO: Company Future Sales Volume|Company Future Revenue RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Company Projected Revenue|APDN - Company Future Sales|Company Future Sales Volume BLUE|Projected Sales Volume immunoprecise.com|Projected Sales Volume OMGA|Company Future Sales Singular Genomics Corp|Regulus Therapeutics - Company Future Sales Volume|SYRS (Syros Pharmaceuticals) - Company Expected Revenue|Telesis Bio Inc. - Projected Sales Volume|Company Future Revenue TCON (TRACON Pharmaceuticals Inc.)|UBX: Projected Sales Volume